TY - JOUR
T1 - Risk of conventional cardiac surgery among patients with severe left ventricular dysfunction in the era of mechanical circulatory support
AU - Thalji, Nassir M.
AU - Maltais, Simon
AU - Daly, Richard C.
AU - Greason, Kevin L.
AU - Schaff, Hartzell V.
AU - Dunlay, Shannon M.
AU - Stulak, John M.
N1 - Funding Information:
Supported by the Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
Funding Information:
Dr Maltais receives research funding from the National Institutes of Health and Clearflow, Inc, and serves on the advisory board of Abbott and Medtronic. All other authors have nothing to disclose with regard to commercial support.
Publisher Copyright:
© 2018 The American Association for Thoracic Surgery
PY - 2018/10
Y1 - 2018/10
N2 - Background: Despite suggestions that severe left ventricle dysfunction may warrant selection of durable mechanical circulatory support over conventional surgery, comparative studies are lacking due to incomplete characterization of patients at highest risk after conventional surgery. We sought to define subsets of patients with severe left ventricle dysfunction who are at greatest mortality risk following conventional cardiac surgery. Methods: We studied 892 patients aged ≥ 18 years who underwent conventional coronary or valve surgery from 1993 to 2014, with preoperative ejection fraction ≤ 25%. Exclusions were transcatheter interventions, major concomitant procedures, active endocarditis, and prior/concurrent durable mechanical circulatory support use. Logistic and Cox regression identified determinants of early and late mortality. Results: Median age was 70 years (interquartile range, 62-76 years), 46% (n = 411) had New York Heart Association (NYHA) functional class IV symptoms, and 16% (n = 142) had undergone prior surgery. Operative mortality was 7.5%. NYHA functional class IV (odds ratio [OR], 1.88; P =.033), prior cardiac surgery (OR, 2.13; P =.017), peripheral vascular disease (OR, 2.55; P =.001), emergency status (OR, 2.68; P =.024), and intra-aortic balloon pump use (OR, 4.95; P <.001) independently predicted operative death. Risk imparted by presence of both NYHA functional class IV symptoms and prior surgery was additive, with a 4-fold increase in early mortality risk (OR, 3.95; P =.003). Prior surgery increased the hazard of late death by 60% (P <.001). In patients without prior surgery, late mortality was greatest in those aged ≥ 70 years (hazard ratio, 1.86; P <.001), especially if NYHA functional class IV symptoms were concurrently present (hazard ratio, 2.25; P <.001). Surgery type (coronary artery bypass graft surgery, aortic valve surgery, or mitral valve surgery) did not predict long-term outcome. Conclusions: In patients referred for conventional surgery with an ejection fraction ≤ 25%, prior cardiac surgery, and/or NYHA functional class IV symptoms—particularly in those aged ≥ 70 years—confer significant and sustained survival disadvantages. Such high-risk subsets may benefit from durable mechanical circulatory support consideration.
AB - Background: Despite suggestions that severe left ventricle dysfunction may warrant selection of durable mechanical circulatory support over conventional surgery, comparative studies are lacking due to incomplete characterization of patients at highest risk after conventional surgery. We sought to define subsets of patients with severe left ventricle dysfunction who are at greatest mortality risk following conventional cardiac surgery. Methods: We studied 892 patients aged ≥ 18 years who underwent conventional coronary or valve surgery from 1993 to 2014, with preoperative ejection fraction ≤ 25%. Exclusions were transcatheter interventions, major concomitant procedures, active endocarditis, and prior/concurrent durable mechanical circulatory support use. Logistic and Cox regression identified determinants of early and late mortality. Results: Median age was 70 years (interquartile range, 62-76 years), 46% (n = 411) had New York Heart Association (NYHA) functional class IV symptoms, and 16% (n = 142) had undergone prior surgery. Operative mortality was 7.5%. NYHA functional class IV (odds ratio [OR], 1.88; P =.033), prior cardiac surgery (OR, 2.13; P =.017), peripheral vascular disease (OR, 2.55; P =.001), emergency status (OR, 2.68; P =.024), and intra-aortic balloon pump use (OR, 4.95; P <.001) independently predicted operative death. Risk imparted by presence of both NYHA functional class IV symptoms and prior surgery was additive, with a 4-fold increase in early mortality risk (OR, 3.95; P =.003). Prior surgery increased the hazard of late death by 60% (P <.001). In patients without prior surgery, late mortality was greatest in those aged ≥ 70 years (hazard ratio, 1.86; P <.001), especially if NYHA functional class IV symptoms were concurrently present (hazard ratio, 2.25; P <.001). Surgery type (coronary artery bypass graft surgery, aortic valve surgery, or mitral valve surgery) did not predict long-term outcome. Conclusions: In patients referred for conventional surgery with an ejection fraction ≤ 25%, prior cardiac surgery, and/or NYHA functional class IV symptoms—particularly in those aged ≥ 70 years—confer significant and sustained survival disadvantages. Such high-risk subsets may benefit from durable mechanical circulatory support consideration.
KW - coronary artery bypass
KW - heart failure
KW - valve surgery
KW - ventricular dysfunction
UR - http://www.scopus.com/inward/record.url?scp=85053496010&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053496010&partnerID=8YFLogxK
U2 - 10.1016/j.jtcvs.2018.04.130
DO - 10.1016/j.jtcvs.2018.04.130
M3 - Article
C2 - 30248795
AN - SCOPUS:85053496010
SN - 0022-5223
VL - 156
SP - 1530-1540.e2
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
IS - 4
ER -